Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
10,078 total articles
Willis Towers Watson (NYSE: WTW) announced the addition of Alex Holderness and Tim Oliver to its North America Outsourcing Sales team effective June 1, 2026. Both hires bring over 30 years of industry experience in benefits administration, healthcare navigation, and strategic sales leadership. This move aligns with WTW's continued investment in exp…
Geron Corporation announced its participation at the Goldman Sachs 47th Annual Global Healthcare Conference, where management will discuss their commercial-stage biopharmaceutical developments, including the approved telomerase inhibitor RYTELO® (imetelstat) and ongoing Phase 3 clinical trials for hematologic malignancies.
Enlivex Ltd. announced that its Phase IIa clinical trial data for Allocetra, an immunotherapy targeting moderate-to-severe knee osteoarthritis, will be presented at the EULAR 2026 congress. The data show durable and statistically significant improvements in pain reduction and function over 6 months versus placebo. These findings support the ongoing…
House of Doge, the corporate arm of the Dogecoin Foundation and merger partner with Brag House Holdings (NASDAQ:TBH), announced a strategic partnership with Paxos to integrate Dogecoin (DOGE) into Paxos' regulated crypto brokerage and custody platform. This integration will make Dogecoin accessible to hundreds of millions of users via Paxos' enterp…
Genius Group Limited (NYSE: GNS) announced an investor call to discuss its new AI Treasury and AGI Infinity Portfolio, initiating up to $100 million investment focusing on pre-IPO stakes in prominent frontier AI companies such as SpaceX, OpenAI, Anthropic, and Figure AI. The Company outlined a five-year plan to expand the portfolio up to $800 milli…
Caring Brands Inc. and SanPellegrino Cosmetics Private Limited have expanded their multi-territory licensing agreement for Photocil and Hair Enzyme Booster. The revised five-year agreement broadens the commercial reach to include India, LATAM, Russia, Australia, and New Zealand. Both products have demonstrated strong clinical acceptance and commerc…
GT Biopharma announced successful integration of AI-based tools in their drug discovery process, enhancing the identification and engineering of tumor-targeting engagers and multi-domain proteins. This technological advancement is expected to shorten development timelines, reduce costs, and increase the likelihood of clinical success. The company a…
Silicon Valley Acquisition Corp., a Nasdaq-listed SPAC focusing on high-growth sectors, has appointed Melbourne Capital Group as its strategic advisor. This partnership aims to enhance Silicon Valley's access to high-quality opportunities in Asia-Pacific markets. The collaboration leverages Melbourne Capital's strong regional presence and Silicon V…
Rapid7, a leader in AI-powered managed cybersecurity operations, appointed Wael Mohamed as CEO, transitioning founder Corey Thomas to Executive Chairman, while reaffirming its financial guidance for 2026. The leadership change aims to accelerate growth in the AI-SOC market, supported by strategic acquisitions and an expanded senior leadership team …
Kayne Anderson Energy Infrastructure Fund, Inc. announced a monthly distribution of $0.085 per share payable on June 30, 2026. The fund focuses on investing in securities of Energy Infrastructure Companies and aims to provide high after-tax total return with an emphasis on cash distributions. The distribution amount may vary and is subject to board…
PMGC Holdings Inc. has signed a non-binding Letter of Intent to acquire a 76% controlling stake in a U.S.-based precision machining company specializing in high-tolerance CNC machining for aerospace, space, defense, semiconductor, and other industrial sectors. The target company is certified and compliant with industry standards, has recurring reve…
Immuneering Corporation announced updated data from its Phase 2a trial showing a median overall survival of 17.3 months in first-line metastatic pancreatic cancer patients treated with atebimetinib plus modified gemcitabine/nab-paclitaxel chemotherapy, nearly double the survival seen in historical controls. The treatment demonstrated a favorable sa…
XCHG Limited, a Nasdaq-listed integrated EV charging and energy solutions company, appointed Albina Iljasov as Co-Chief Executive Officer effective June 1, 2026. Iljasov will oversee European operations and spearhead information security and cybersecurity efforts, complementing existing Co-CEO Yifei Hou. The move signals XCharge's commitment to glo…
Iovance Biotherapeutics announced FDA clearance of their investigational new drug (IND) application for IOV-5001, a next-generation interleukin-12 (IL-12) tethered tumor infiltrating lymphocyte (TIL) therapy. The Phase 1/2 trial aims to treat multiple advanced solid tumors including colorectal and breast cancers, with enrollment expected in the sec…
SL Green Realty Corp., Manhattan's largest office landlord, announced the sale of 10 East 53rd Street to Meadow Partners for $312.2 million. The sale, expected to close in Q3 2026, will generate approximately $100 million in net cash proceeds to reduce corporate debt. This transaction advances SL Green's $2.5 billion strategic disposition plan and …
Anterix Inc., a leading provider of private wireless broadband spectrum solutions for critical infrastructure, announced its fourth quarter fiscal 2026 earnings conference call will take place on June 11, 2026. The company will discuss its quarterly results following a press release after market close on June 10. Anterix continues to focus on deliv…
Cognition Therapeutics, a clinical-stage biopharmaceutical company focused on neurodegenerative diseases, announced CEO Lisa Ricciardi will present at two upcoming investor conferences, sharing updates on the company's development plans for its lead drug candidate zervimesine (CT1812), targeting dementia with Lewy bodies (DLB) psychosis. The compan…
Cytokinetics announced the commercial launch of MYQORZO® (aficamten) in Germany, marking its first European availability for symptomatic obstructive hypertrophic cardiomyopathy (oHCM). This follows FDA approval and market introduction in the U.S. and China. The European Commission approved MYQORZO based on positive Phase 3 clinical trial results de…
OptimizeRx Corp., a healthcare technology company specializing in AI-driven marketing solutions for life sciences, announced that its management will participate in prominent investor conferences including the Stifel 2026 Boston Cross Sector Conference and the 46th Annual William Blair Growth Stock Conference. The participation aims to showcase the…
TG Therapeutics announced publication of post-hoc pooled analyses from the Phase 3 ULTIMATE I & II trials demonstrating that BRIUMVI (ublituximab-xiiy) provides significant clinical and MRI improvements versus teriflunomide in treatment-naïve adult patients with relapsing multiple sclerosis (RMS). The data supports early use of this high-efficacy t…
Intellia Therapeutics announced it will present additional data from its global Phase 3 HAELO trial of lonvo-z, a one-time CRISPR-based gene editing therapy for hereditary angioedema (HAE), at the EAACI 2026 Congress. This late-breaking oral presentation highlights the potential of lonvo-z to become the first permanent treatment to prevent HAE atta…
Athene, a leading retirement solutions company and subsidiary of Apollo Global Management, appointed Matthew Michelini as President of Athene Holding Ltd., effective July 1, 2026. Michelini brings extensive experience from Apollo, including leadership in Asia-Pacific, and will focus on advancing growth initiatives and reinventing guaranteed lifetim…
HCI Group successfully completed its 2026-2027 catastrophe reinsurance programs, securing $4.1 billion in excess of loss coverage, a 16% increase year-over-year, while reducing net reinsurance premiums by 10%. The company enhanced its risk transfer strategy with meaningful structural improvements and expanded participation of its Cayman Islands rei…
Nayax Ltd., a global payments and commerce enablement platform, launched a new AI-powered product discovery and personalization feature integrated into its platform. This solution helps retailers utilize real-time shopper data across multiple channels to provide personalized recommendations, thereby increasing customer engagement and sales. The pro…
Helus Pharma, a clinical-stage pharmaceutical company developing novel serotonergic agonists for mental health conditions, announced that Interim CEO Eric So will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York on June 4, 2026. The company is advancing proprietary drugs HLP003 and HLP004 for major depressive…
